Total adverse events · people with chronic gout
Benzbromarone showed no clear difference in total adverse events compared with allopurinol (low certainty).
1 finding from 1 review
Pain reduction ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Function ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Tophus regression ‐ not measured · people with chronic gout
The review found no eligible studies for this question.
1 finding from 1 review
Acute gout attacks · people with chronic gout
Benzbromarone showed no clear difference in acute gout attacks compared with probenecid (low certainty).
1 finding from 1 review
Serum urate normalisation ≤ 5 mg/dL (≤ 0.3 mmol/L) · people with chronic gout
Benzbromarone probably leads to higher serum urate normalisation ≤ 5 mg/dL (≤ 0.3 mmol/L) compared with probenecid (moderate certainty).
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Function (change from baseline) Shoulder Pain and Disability Questionnaire (SPADI, 0‐100) (lower scores = better function)f · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Global assessment of treatment success · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Active shoulder abduction · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of Life: SF‐36 (physical component) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Adverse events · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Participant‐reported pain relief of 30% or greater · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain (change from baseline) Shoulder Pain and Disability Questionnaire (SPADI, 0‐100) (lower scores = less pain)a · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Function (change from baseline) Shoulder Pain and Disability Questionnaire (SPADI, 0‐100) (lower scores = better function)f · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Global assessment of treatment success · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Active shoulder abduction · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Overall pain (change from baseline) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Quality of Life: SF‐36 (physical component) · patients with adhesive capsulitis (frozen shoulder)
1 finding from 1 review
Adverse events · patients with adhesive capsulitis (frozen shoulder)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found